Phase 3 Lupus clinical trials

12 recruiting Phase 3 lupus studies in the US. What trial phases mean

Other phases

RecruitingPhase 3NCT06617325

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sponsor: UCB Biopharma SRL

Avondale, AZ · Chandler, AZ · Gilbert, AZ · +60 more sites

RecruitingPhase 3NCT06133972

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Sponsor: Novartis Pharmaceuticals

Anniston, AL · Burbank, CA · La Palma, CA · +22 more sites

RecruitingPhase 3NCT06711887

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Sponsor: Novartis Pharmaceuticals

Orchard Park, NY

RecruitingPhase 3NCT07332481

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Sponsor: EMD Serono Research & Development Institute, Inc.

Los Angeles, CA · Thousand Oaks, CA · Cooper City, FL · +9 more sites

RecruitingPhase 3NCT07355218

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Sponsor: EMD Serono Research & Development Institute, Inc.

Upland, CA · DeBary, FL · Fort Lauderdale, FL · +11 more sites

RecruitingPhase 3NCT07691970

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Sponsor: AstraZeneca

Phoenix, AZ · Los Angeles, CA · San Francisco, CA · +12 more sites

RecruitingPhase 3NCT05835310

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Sponsor: AstraZeneca

Phoenix, AZ · Los Angeles, CA · Washington D.C., DC · +19 more sites

RecruitingPhase 3NCT07430306

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Sponsor: AstraZeneca

Anniston, AL · Birmingham, AL · Phoenix, AZ · +28 more sites

RecruitingPhase 3NCT07438496

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Sponsor: Janssen Research & Development, LLC

Beverly Hills, CA · Fullerton, CA · Hemet, CA · +35 more sites

RecruitingPhase 3NCT05799378

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

Sponsor: NYU Langone Health

Los Angeles, CA · San Diego, CA · Atlanta, GA · +9 more sites

RecruitingPhase 3NCT07201129

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Sponsor: Viatris Innovation GmbH

Doral, FL · Kissimmee, FL · Miami, FL · +11 more sites

Not yet recruitingPhase 3NCT07840287

A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestations Of Lupus With Or Without Systemic Disease [Elowen-LTE]

Sponsor: EMD Serono Research & Development Institute, Inc.

Billerica, MA

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.